Concepedia

Jessalyn J. Baljon

JJ

10

Publications

1.1K

Citations

10

H-Index

2017

Active since

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

VA Tennessee Valley Healthcare System

University of California, Los Angeles

Jessalyn J. Baljon is an author at Vanderbilt University specializing in engineering, medicine, and nanomedicine.

ORCID

Top concepts

Publications per year

2017–2024

10

Publications

10

Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering

Zhong‐Kai Cui, Soyon Kim, Jessalyn J. Baljon et al. · Nature Communications · 2019 · 425 citations · Full text

Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines

Daniel Shae, Jessalyn J. Baljon, Mohamed Wehbe et al. · ACS Nano · 2020 · 153 citations · Full text

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Mohamed Wehbe, Lihong Wang-Bishop, Kyle W. Becker et al. · Journal of Controlled Release · 2020 · 112 citations · Full text

, , +9

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa et al. · Science Immunology · 2023 · 106 citations · Full text

, , +17

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm et al. · ACS Nano · 2024 · 87 citations · Full text

Rows per page

1–5 of 10